HistoSonics Announces $2.25B Management-Led Majority Stake Acquisition by Syndicate Including K5 Global, Bezos Expeditions, and Wellington Management

Boston Scientific to Acquire SoniVie Ltd

March 3, 2025

Medical Devices

Boston Scientific Corporation has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company developing the TIVUS intravascular ultrasound system for renal denervation therapy for hypertension. The deal includes an upfront payment of approximately $360 million for the 90% stake Boston Scientific does not already own, plus up to $180 million contingent on achievement of a regulatory milestone.

Hologic Acquires Gynesonics

January 6, 2025

Medical Devices

Hologic, Inc. completed its previously announced acquisition of Gynesonics, a privately held medical device company focused on minimally invasive solutions for women’s health, for about $350 million. Gynesonics develops the Sonata System for diagnostic intrauterine imaging and incision-less transcervical treatment of certain symptomatic uterine fibroids.

Edison Partners Makes $15M Growth Investment in Seismos

July 10, 2024

Energy

Edison Partners has made a $15 million growth equity investment in Seismos to accelerate the adoption of its AI-powered acoustic sensing platform across oil & gas and into new end markets such as geothermal and mining. The capital will support Seismos' global expansion, product scaling, and commercialization of its predictive analytics and digital infrastructure solutions from its Austin, Texas headquarters.

Johnson & Johnson to Acquire Shockwave Medical for $13.1 Billion

April 5, 2024

Healthcare Services

Johnson & Johnson (JNJ) entered into a definitive agreement to acquire all outstanding shares of Shockwave Medical for $335.00 per share in cash, implying an enterprise value of about $13.1 billion. The deal expands J&J MedTech’s cardiovascular intervention portfolio—adding Shockwave’s intravascular lithotripsy (IVL) technology for calcified coronary and peripheral artery disease.

Bioventus Inc. Acquires Misonix, Inc.

July 29, 2021

Medical Devices

Bioventus Inc. entered into a definitive agreement to acquire Misonix, Inc. in a cash-and-stock transaction that values Misonix at approximately $518 million on a fully diluted basis. The deal expands Bioventus' regenerative medicine and surgical solutions portfolio by adding Misonix's minimally invasive ultrasonic technologies and regenerative wound products and is expected to close in the fourth quarter of 2021 subject to customary approvals.

Johnson & Johnson (Ethicon) Acquires Auris Health

April 1, 2019

Medical Devices

Johnson & Johnson, through its surgical devices unit Ethicon, completed the acquisition of Auris Health, Inc. for approximately $3.4 billion in cash with up to $2.35 billion in contingent payments. The deal brings Auris' Monarch robotic bronchoscopy platform and related digital surgery capabilities into J&J's medical devices portfolio to accelerate capability expansion in digital and robotic surgery, particularly for lung cancer diagnosis and intervention.